<http://schema.org/description>
"With the release of phase 2 data from Merck\u00A0 and phase 3 data from Bristol-Myers Squibb\u00A0 , the race for the new hepatitis C combination treatment is heating up. While leader Gilead Sciences waits"^^<http://www.w3.org/2001/XMLSchema#string>
<http://www.aol.com/article/2014/04/15/can-merck-co-inc-and-bristol-myers-squibb-co-dethr/20869442/>